Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 10/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 10/20 | 0.47 |
| ▸ | CTSK | P43235 | 6/20 | 0.44 |
| ▸ | CTSS | P25774 | 3/20 | 0.44 |
| ▸ | CTSL | P07711 | 2/20 | 0.43 |
| ▸ | CTSB | P07858 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14850855 | 1.00 | ITGB3 (0.47) | ITGB3ITGA2BCTSKCTSSCTSL | |
| SCHEMBL14850864 | 0.99 | ITGB3 (0.46) | ITGB3ITGA2BCTSKCTSSCTSL | |
| SCHEMBL14850788 | 0.94 | ITGB3 (0.45) | ITGB3ITGA2BCTSKCTSSCTSL | |
| SCHEMBL16435346 | 0.93 | CTSS (0.45) | ITGB3ITGA2BCTSKCTSSCTSL | |
| SCHEMBL14850693 | 0.88 | TSHR (0.41) | ITGB3ITGA2BCTSKCTSSCTSL | |
| SCHEMBL556760 | 0.87 | CTSK (0.44) | ITGB3ITGA2BCTSKCTSSCTSL | |
| SCHEMBL29990568 | 0.86 | TSHR (0.41) | ITGB3ITGA2BCTSKCTSSCTSL | |
| SCHEMBL14850695 | 0.86 | TSHR (0.41) | ITGB3ITGA2BCTSKCTSSCTSL | |
| SCHEMBL16435378 | 0.86 | CTSK (0.48) | ITGB3ITGA2BCTSKCTSSCTSL | |
| SCHEMBL16435379 | 0.86 | PREP (0.48) | ITGB3ITGA2BCTSKCTSSCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150038493-A1 | COMPOUNDS THAT TRAP ALPHA-OXOALDEHYDES AND ALPHA-BETA-UNSATURATED ALDEHYDES, META-COMPOUNDS CONTAINING SUCH COMPOUNDS, AND USE OF SAID COMPOUNDS IN TREATING ILLNESSES RELATED TO THE ACCUMULATION OF AGES AND ALES | PHARMAMENS (FR) | 2015-02-05 | — | — | US | disclosed |
| WO-2013050721-A1 | COMPOUNDS THAT TRAP ALPHA-OXOALDEHYDES AND ALPHA-BETA-UNSATURATED ALDEHYDES, META-COMPOUNDS CONTAINING SUCH COMPOUNDS, AND USE OF SAID COMPOUNDS IN TREATING ILLNESSES RELATED TO THE ACCUMULATION OF AGES AND ALES | PHARMAMENS (FR) | 2013-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150038493-A1 | COMPOUNDS THAT TRAP ALPHA-OXOALDEHYDES AND ALPHA-BETA-UNSATURATED ALDEHYDES, META-COMPOUNDS CONTAINING SUCH COMPOUNDS, AND USE OF SAID COMPOUNDS IN TREATING ILLNESSES RELATED TO THE ACCUMULATION OF AGES AND ALES | AOX1, TYR, HAO1 | ITGB3 2058/4885ITGA2B 2271/4885CTSK 1558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.